{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:36:00Z","timestamp":1791916560921,"version":"4.3.4"},"reference-count":48,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,3,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The targeting of BCR-ABL, a hybrid oncogenic tyrosine (Y) kinase, does not eradicate chronic myeloid leukemia (CML)\u2013initiating cells. Activation of \u03b2-catenin was linked to CML leukemogenesis and drug resistance through its BCR-ABL\u2013dependent Y phosphorylation and impaired binding to GSK3\u03b2 (glycogen synthase kinase 3\u03b2). Herein, we show that GSK3\u03b2 is constitutively Y216 phospho-activated and predominantly relocated to the cytoplasm in primary CML stem\/progenitor cells compared with its balanced active\/inactive levels and cytosolic\/nuclear distribution in normal cells. Under cytokine support, persistent GSK3\u03b2 activity and its altered subcellular localization were correlated with BCR-ABL\u2013dependent and \u2013independent activation of MAPK and p60-SRC\/GSK3\u03b2 complex formation. Specifically, GSK3\u03b2 activity and nuclear import were increased by imatinib mesylate (IM), a selective ABL inhibitor, but prevented by dasatinib that targets both BCR-ABL\u2013 and cytokine-dependent MAPK\/p60-SRC activity. SB216763, a specific GSK3 inhibitor, promoted an almost complete suppression of primary CML stem\/progenitor cells when combined with IM, but not dasatinib, while sparing bcr-abl\u2013negative cells. Our data indicate that GSK3 inhibition acts to prime a pro-differentiative\/apoptotic transcription program in the nucleus of IM-treated CML cells by affecting the \u03b2-catenin, cyclinD1, C-EBP\u03b1, ATF5, mTOR, and p27 levels. In conclusion, our data gain new insight in CML biology, indicating that GSK3 inhibitors may be of therapeutic value in selectively targeting leukemia-initiating cells in combination with IM but not dasatinib.<\/jats:p>","DOI":"10.1182\/blood-2011-06-361261","type":"journal-article","created":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T02:13:49Z","timestamp":1327025629000},"page":"2335-2345","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["Targeting of GSK3\u03b2 promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells"],"prefix":"10.1182","volume":"119","author":[{"given":"Giovanni","family":"Reddiconto","sequence":"first","affiliation":[{"name":"Hematology Unit, Vito Fazzi Hospital Azienda Sanitaria Locale Leece (ASL[LE]), Lecce, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Toto","sequence":"additional","affiliation":[{"name":"Clinical Proteomics Research Unit, Vito Fazzi Hospital ASL (LE),"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Palam\u00e0","sequence":"additional","affiliation":[{"name":"Institute of Nanoscience, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"De Leo","sequence":"additional","affiliation":[{"name":"Clinical Proteomics Research Unit, Vito Fazzi Hospital ASL (LE),"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"de Luca","sequence":"additional","affiliation":[{"name":"Clinical Proteomics Research Unit, Vito Fazzi Hospital ASL (LE),"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"De Matteis","sequence":"additional","affiliation":[{"name":"Department of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Dini","sequence":"additional","affiliation":[{"name":"Department of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Gambacorti","family":"Passerini","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Di Renzo","sequence":"additional","affiliation":[{"name":"Hematology Unit, Vito Fazzi Hospital Azienda Sanitaria Locale Leece (ASL[LE]), Lecce, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Maffia","sequence":"additional","affiliation":[{"name":"Clinical Proteomics Research Unit, Vito Fazzi Hospital ASL (LE),"},{"name":"Department of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addolorata Maria Luce","family":"Coluccia","sequence":"additional","affiliation":[{"name":"Hematology Unit, Vito Fazzi Hospital Azienda Sanitaria Locale Leece (ASL[LE]), Lecce, Italy;"},{"name":"Clinical Proteomics Research Unit, Vito Fazzi Hospital ASL (LE),"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2019111808145369500_B1","doi-asserted-by":"crossref","first-page":"e1000447","DOI":"10.1371\/journal.pcbi.1000447","article-title":"Stem cell proliferation and quiescence-two sides of the same coin.","volume":"5","author":"Glauche","year":"2009","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"2019111808145369500_B2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog Neurobiol"},{"issue":"12","key":"2019111808145369500_B3","first-page":"3519","article-title":"Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice.","volume":"119","author":"Huang","year":"2009","journal-title":"J Clin Invest"},{"issue":"6880","key":"2019111808145369500_B4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature733","article-title":"Shaggy\/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus.","volume":"416","author":"Jia","year":"2002","journal-title":"Nature"},{"issue":"12","key":"2019111808145369500_B5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0960-9822(02)00888-6","article-title":"Glycogen synthase kinase-3beta modulates Notch signalling and stability.","volume":"12","author":"Foltz","year":"2002","journal-title":"Curr Biol"},{"issue":"6938","key":"2019111808145369500_B6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature01593","article-title":"A role for Wnt signalling in self-renewal of haematopoietic stem cells.","volume":"423","author":"Reya","year":"2003","journal-title":"Nature"},{"issue":"1","key":"2019111808145369500_B7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm979","article-title":"Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3 specific inhibitor.","volume":"10","author":"Sato","year":"2004","journal-title":"Nat Med"},{"issue":"1","key":"2019111808145369500_B8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nm1339","article-title":"Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation.","volume":"12","author":"Trowbridge","year":"2006","journal-title":"Nat Med"},{"issue":"6","key":"2019111808145369500_B9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ccr.2010.05.017","article-title":"Glycogen synthase kinase-3 and leukemia: restoring the balance.","volume":"17","author":"Birch","year":"2010","journal-title":"Cancer Cell"},{"issue":"7217","key":"2019111808145369500_B10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nature07284","article-title":"Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.","volume":"455","author":"Wang","year":"2008","journal-title":"Nature"},{"issue":"6","key":"2019111808145369500_B11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ccr.2010.04.024","article-title":"GSK-3 promotes conditional association of CREB and its co-activators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis.","volume":"17","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"issue":"4","key":"2019111808145369500_B12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.molcel.2007.11.009","article-title":"GSK-3-mediated phosphorylation enhances Maf-transforming activity.","volume":"28","author":"Rocques","year":"2007","journal-title":"Mol Cell"},{"issue":"11","key":"2019111808145369500_B13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/leu.2010.159","article-title":"Insights into the stem cells of chronic myeloid leukemia.","volume":"24","author":"Sloma","year":"2010","journal-title":"Leukemia"},{"key":"2019111808145369500_B14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/stem.5530160809","article-title":"Differences between normal and CML stem cells: potential targets for clinical exploitation.","volume":"16","author":"Eaves","year":"1998","journal-title":"Stem Cells"},{"issue":"6","key":"2019111808145369500_B15","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"issue":"12","key":"2019111808145369500_B16","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0301-472X(00)00545-2","article-title":"Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.","volume":"28","author":"Bhatia","year":"2000","journal-title":"Exp Hematol"},{"key":"2019111808145369500_B17","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1073\/pnas.89.13.6192","article-title":"Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.","volume":"89","author":"Udomsakdi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111808145369500_B18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.","volume":"351","author":"Jamieson","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111808145369500_B19","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1073\/pnas.0900189106","article-title":"Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.","volume":"106","author":"Abrahamsson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111808145369500_B20","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601485","article-title":"Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.","volume":"26","author":"Coluccia","year":"2007","journal-title":"EMBO J"},{"key":"2019111808145369500_B21","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4161\/cc.5.24.3573","article-title":"Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia.","volume":"5","author":"Barnes","year":"2006","journal-title":"Cell Cycle"},{"issue":"10","key":"2019111808145369500_B22","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V99.10.3792","article-title":"Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation.","volume":"99","author":"Holtz","year":"2002","journal-title":"Blood"},{"issue":"12","key":"2019111808145369500_B23","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"issue":"1","key":"2019111808145369500_B24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111808145369500_B25","first-page":"3","article-title":"Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles.","volume":"66","author":"Biederbick","year":"1995","journal-title":"Eur J Cell Biol"},{"issue":"4","key":"2019111808145369500_B26","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1073\/pnas.93.4.1470","article-title":"Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.","volume":"93","author":"Petzer","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111808145369500_B27","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1073\/pnas.94.9.4698","article-title":"Cytokine manipulation of primitive human hematopoietic cell self-renewal.","volume":"94","author":"Zandstra","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"2019111808145369500_B28","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-06-4312","article-title":"BCR-tyrosine 177 plays an essential role in Ras and AKT activation in human hematopoietic progenitor transformation in chronic myelogenous leukemia.","volume":"67","author":"Chu","year":"2007","journal-title":"Cancer Res"},{"issue":"8","key":"2019111808145369500_B29","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2003-04-1271","article-title":"BCR\/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells.","volume":"103","author":"Chu","year":"2004","journal-title":"Blood"},{"issue":"13","key":"2019111808145369500_B30","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-06-0025","article-title":"Janus kinase 2: a critical target in chronic myelogenous leukemia.","volume":"66","author":"Samanta","year":"2006","journal-title":"Cancer Res"},{"issue":"24","key":"2019111808145369500_B31","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.","volume":"354","author":"Talpaz","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111808145369500_B32","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction.","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"issue":"23","key":"2019111808145369500_B33","doi-asserted-by":"crossref","first-page":"9624","DOI":"10.1158\/0008-5472.CAN-08-1131","article-title":"Effects of Dasatinib on Src kinase activity and downstream intracellular signalling in primitive chronic myelogenous leukemia hematopoietic cells.","volume":"68","author":"Konig","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"2019111808145369500_B34","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2010-12-322537","article-title":"BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription.","volume":"118","author":"Sheng","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111808145369500_B35","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.","volume":"119","author":"Bellodi","year":"2009","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111808145369500_B36","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","article-title":"Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.","volume":"105","author":"Dajani","year":"2001","journal-title":"Cell"},{"issue":"pt 1","key":"2019111808145369500_B37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj20031259","article-title":"Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event.","volume":"377","author":"Cole","year":"2004","journal-title":"Biochem J"},{"issue":"2","key":"2019111808145369500_B38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/bbrc.2001.4986","article-title":"Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2.","volume":"284","author":"Hartigan","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2019111808145369500_B39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bbrc.2004.02.061","article-title":"Glycogen synthase kinase-3beta is tyrosine-phosphorylated by MEK1 in human skin fibroblasts.","volume":"316","author":"Takahashi-Yanaga","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2019111808145369500_B40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1471-4159.1999.0720576.x","article-title":"Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase.","volume":"72","author":"Lesort","year":"1999","journal-title":"J Neurochem"},{"issue":"7281","key":"2019111808145369500_B41","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"issue":"8","key":"2019111808145369500_B42","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/MCB.01405-08","article-title":"Subcellular localization of glycogen synthase kinase 3beta controls embryonic stem cell self-renewal.","volume":"29","author":"Bechard","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"23","key":"2019111808145369500_B43","doi-asserted-by":"crossref","first-page":"16989","DOI":"10.1074\/jbc.M700610200","article-title":"Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis.","volume":"282","author":"Meares","year":"2007","journal-title":"J Biol Chem"},{"issue":"20","key":"2019111808145369500_B44","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1073\/pnas.190297597","article-title":"Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration.","volume":"97","author":"Bhat","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111808145369500_B45","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/leu.2010.24","article-title":"Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.","volume":"24","author":"Chu","year":"2010","journal-title":"Leukemia"},{"key":"2019111808145369500_B46","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1038\/onc.2010.67","article-title":"Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming.","volume":"29","author":"Zhao","year":"2010","journal-title":"Oncogene"},{"issue":"5","key":"2019111808145369500_B47","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1016\/j.leukres.2009.11.021","article-title":"Modifications of fasting glucose values as first sign of resistance in chronic myeloid leukemia chronic phase patients during imatinib treatment.","volume":"34","author":"Breccia","year":"2010","journal-title":"Leuk Res"},{"issue":"10","key":"2019111808145369500_B48","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.leukres.2008.01.015","article-title":"Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib.","volume":"32","author":"Breccia","year":"2008","journal-title":"Leuk Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/10\/2335\/1349398\/zh801012002335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/10\/2335\/1349398\/zh801012002335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:35:29Z","timestamp":1574084129000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/10\/2335\/29563\/Targeting-of-GSK3%CE%B2-promotes-imatinibmediated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,8]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,3,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-06-361261","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,8]]}}}